AtriCure Inc. ATRC Stock Quotes and Insider News

Insider Chart Past 6 Months

Technical Chart

Filings by transaction date

Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Carrel Michael H

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-25,000

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Carrel Michael H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-25,000

Price:

$59.00
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Carrel Michael H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

25,000

Price:

$21.04
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Collar Mark A

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-3,000

Price:

$55.36
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Noznesky Justin J

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-15,000

Price:

--
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Noznesky Justin J

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-8,397

Price:

$53.61
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Noznesky Justin J

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-15,000

Price:

$53.57
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Noznesky Justin J

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

15,000

Price:

$18.30
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Privitera Salvatore

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

184

Price:

$38.48
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Wirick Angela L

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

240

Price:

$38.48

Filings by filing date

Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Carrel Michael H

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-25,000

Price:

--
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Carrel Michael H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-25,000

Price:

$59.00
Jan 11, 2021 (filed on Jan 13, 2021)

Insider Name:

Carrel Michael H

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

25,000

Price:

$21.04
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Collar Mark A

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-3,000

Price:

$55.36
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Noznesky Justin J

Ownership Type:

Direct Ownership

Securities:

Stock Option (Right to Buy)

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

-15,000

Price:

--
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Noznesky Justin J

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-8,397

Price:

$53.61
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Noznesky Justin J

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

S - Open market or private sale

# or value acquired/disposed of:

-15,000

Price:

$53.57
Jan 04, 2021 (filed on Jan 06, 2021)

Insider Name:

Noznesky Justin J

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

M - Exercise or conversion exempt under rule 16b-3

# or value acquired/disposed of:

15,000

Price:

$18.30
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Privitera Salvatore

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

184

Price:

$38.48
Dec 31, 2020 (filed on Jan 04, 2021)

Insider Name:

Wirick Angela L

Ownership Type:

Direct Ownership

Securities:

Common Stock

Nature of Transaction:

A - Grant, award or other under Rule 16b-3(d)

# or value acquired/disposed of:

240

Price:

$38.48

News

Biz Brief

Sector: Healthcare	Industry: Medical Equipment, Supplies & Distribution

See Regulatory Filings on SEC

Company Contact

Address:	7555 Innovation Way MASON OH 45040-9695
Tel:	N/A
Website:	https://www.atricure.com
IR:	See website

Key People

Scott William Drake Independent Chairman of the Board	Michael H. Carrel President, Chief Executive Officer, Director	Angela L. Wirick Chief Financial Officer
Douglas J. Seith Chief Operating Officer	Justin J. Noznesky Senior Vice President, Marketing and Business Development	Salvatore Privitera Chief Technology Officer

Business Overview

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. It has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion. The Company also sells Lumitip dissectors and the Estech line of reusable cardiac surgery (valve) instruments. Its cryoICE cryosurgery product line offers various cryoablation devices. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA).

Financial Overview

For the nine months ended 30 September 2020,AtriCure Inc. revenues decreased 12% to $148.8M. Net lossincreased 55% to $29.6M. Revenues reflect MinimallyInvasive Ablation segment decrease of 29% to $18.3M, Openablation -International segment decrease of 27% to $13.8M,United States segment decrease of 11% to $121.8M, Europesegment decrease of 17% to $16.8M.

Employees:	730 as of Jan 31, 2020

Reporting Currency:	U.S. Dollars
Enterprise value:	$2,470M as of Sep 30, 2020
Annual revenue (TTM):	$210.13M as of Sep 30, 2020
EBITDA (TTM):	-$31.96M as of Sep 30, 2020
Net annual income (TTM):	-$45.69M as of Sep 30, 2020
Free cash flow (TTM):	-$35.92M as of Sep 30, 2020
Net Debt Last Fiscal Year:	N/A
Shares outstanding:	45,023,214 as of Nov 4, 2020
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

INK Ultra Money Free

INK Ultra Money Videos

AtriCure Inc. (OQ:ATRC)